Clinical Laboratory in Indiana

MiraVista Diagnostics is a CAP- and CLIA-certified clinical reference laboratory specializing exclusively in diagnostic testing for serious fungal infections. Founded in 2002 by renowned infectious disease scientist Lawrence Joseph Wheat, MD, the company has established itself as the leading authority in mycological diagnostics. MiraVista processes over 100,000 diagnostic tests annually for blastomycosis, histoplasmosis, cryptococcosis, aspergillosis, coccidioidomycosis, and beta-D glucan detection across multiple specimen types including bronchoalveolar lavage (BAL) fluid. The laboratory offers both antigen-detection methods (EIA, latex agglutination) and molecular diagnostic assays, including the newly available MVista® Fungal PCR Panel for pulmonary fungal pathogen multiplex detection. The company provides same-day testing with prompt turnaround times and employs experienced infectious disease specialists. With over 1,000 peer-reviewed publications in leading infectious disease and clinical laboratory journals, MiraVista serves hospital laboratories, clinicians, and researchers requiring high-complexity fungal serology and molecular diagnostics. The organization also operates a parallel veterinary diagnostic division (MiraVistaVets.com). Regulatory compliance includes CAP and CLIA certifications, positioning the laboratory for clinical and reference testing across academic medical centers, community hospitals, and specialized infection control programs.

Analytical Control Systems, Inc. (ACS) is a manufacturer of diagnostic controls, reagents, and quality control products for clinical laboratory and analytical testing applications. Founded in 1978, the company specializes in manufacturing stable protein and enzyme-based products in both lyophilized and liquid formats. ACS operates as an OEM manufacturer serving both laboratory reagent distributors and end-user clinical facilities. The company competes in the quality control market segment, offering proprietary formulations and manufacturing capabilities for diagnostic testing. ACS maintains a catalog of products available through distributors and direct sales channels.

Indigo BioAutomation develops laboratory automation software and data analytics platforms for clinical and life science laboratories. The company's primary offerings are ASCENT, a unified platform for liquid chromatography, gas chromatography, and mass spectrometry (LC/GC-MS/MS) workflow automation and data analysis, and ARQ, a PCR data analysis and automation solution for real-time and quantitative PCR (RT/qPCR) assays. Both products are delivered as SaaS (software-as-a-service) systems, enabling remote access and multi-instrument integration within a single quality framework aligned to laboratory SOPs. ASCENT and ARQ employ advanced algorithms and machine learning to automate complex data interpretation, enable exception-based review ("Releview"), and streamline high-throughput testing workflows. The platform integrates sample tracking, instrument data, and reporting to reduce manual review burden and accelerate turnaround times in clinical diagnostics and research settings. Indigo serves independent diagnostic laboratories, reference labs, test manufacturers, hospital laboratories, and academic medical centers, including Mayo Clinic, Duke Health, ARUP Laboratories, University of Washington, and numerous clinical diagnostic companies. The company emphasizes unified data governance, continuous validation monitoring, and AI-driven operational insights to support quality assurance and process improvement in complex analytical workflows.